Healthcare & Life Sciences
Albireo Pharma, Inc.
United Statesalbireopharma.com
Albireo Pharma, Inc. is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Albireo Pharma, Inc.
Based in the United States, Albireo Pharma, Inc. is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Albireo Pharma, Inc. develops therapies for rare pediatric and adult cholestatic liver diseases, including odevixibat (Bylvay), an approved oral ileal bile acid transporter inhibitor.
Explore Albireo Pharma, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.